Citizendia
Your Ad Here

European Society of Gene Therapy (ESGCT) formerly European Society of Gene Therapy (ESGT) is a legally-registered professional body which emerged from a small working group in 1992 that focused on human gene therapy. Working Group can mean Working group, an interdisciplinary group of researchers or Working Group (dogs, kennel club designation for Year 1992 ( MCMXCII) was a Leap year starting on Wednesday (link will display full 1992 Gregorian calendar) Gene therapy is the insertion of Genes into an individual's cells and tissues to treat a Disease, and Hereditary diseases in which a

The objectives of the ESGT include the following:

The official journal of the ESGT is The Journal of Gene Medicine.

Collaborations

The ESGT works with other entities in the scientific communities in the event that an adverse effect to a specific gene therapy is discovered. In Medicine, an adverse effect is a harmful and undesired effect resulting from a medication or other intervention such as Chemotherapy or Surgery. Investigations the ESGT has been involved with include the adverse effects discovered during the French X-SCID gene therapy trial. X-linked Severe Combined Immunodeficiency (X-SCID is a profound and severe Immunodeficiency characterized by the complete absence of NK cells and T cells The ESGT hosted a forum of 500 researchers from various facilities around the world, including representatives from the Stanford University and the Sloan Kettering Cancer Research Center. Leland Stanford Junior University, commonly known as Stanford University or simply Stanford, is a private Research university located in Memorial Sloan-Kettering Cancer Center (MSKCC is a Cancer treatment and research institution founded in 1884 as the New York Cancer Hospital.

External links


© 2009 citizendia.org; parts available under the terms of GNU Free Documentation License, from http://en.wikipedia.org
Dapyx Software network: MP3 Explorer | Ebook Manager | Zenithic